Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003106165 | SCV003792601 | uncertain significance | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2023-07-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 975449). This variant has not been reported in the literature in individuals affected with MOCS1-related conditions. This variant is present in population databases (rs532400782, gnomAD 0.004%). This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 38 of the MOCS1 protein (p.Ala38Pro). |
Ambry Genetics | RCV003284132 | SCV003957315 | likely benign | Inborn genetic diseases | 2023-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre de Biologie Pathologie Génétique, |
RCV001252078 | SCV001427826 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |